TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Carmel Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
71,574
|
68,085
|
56,467 |
| Financial expenses |
2
|
1
|
8 |
| Earnings before taxes |
82,537
|
68,128
|
58,212 |
| EBITDA |
70,079
|
66,944
|
55,084 |
| Total assets |
452,169
|
492,580
|
424,922 |
| Current assets |
1,810
|
15,594
|
22,015 |
| Current liabilities |
83,963
|
124,424
|
394 |
| Equity capital |
368,206
|
368,156
|
368,241 |
| - share capital |
8,866
|
8,866
|
8,866 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
81.4%
|
74.7%
|
86.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
115.3%
|
100.1%
|
103.1% |
| Return on assets (ROA) |
18.3%
|
13.8%
|
13.7% |
| Current ratio |
2.2%
|
12.5%
|
5587.6% |
| Return on equity (ROE) |
22.4%
|
18.5%
|
15.8% |
| Change turnover |
3,489
|
11,618
|
-9,059 |
| Change turnover % |
5%
|
21%
|
-14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.